The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor Ovarian response

Journal of Assisted Reproduction and Genetics

Volumn 21, Issue 7, 2004, Pages 257-262

  Akande, Valentine A ^a   Keay, Stephen D ^b   Hunt, Linda P ^a   Mathur, Rajneesh S ^c   Jenkins, Julian M ^a   Cahill, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Rosie Maternity Hospital   (United Kingdom)

Author keywords

Age; FSH; infertility; IVF; poor ovarian reponse

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOPHYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY; OVULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; AGING; BIOLOGICAL MARKERS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; OVARY; PREGNANCY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

FALLOPIA;

EID: 4544280105     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JARG.0000042011.67696.85     Document Type: Article

References (44)

1. Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM: Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod 2002;17(8):2003-2008
2. Rojas FJ: Ovulation induction. Effects of ovulation induction with gonadotrophins on the ovary and uterus and their implications for assisted reproduction. Hum Reprod 1995;10(9):2219-2224
3. Keay SD, Liversedge NH, Mathur RS, Jenkins JM: Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104(5):521-527
4. Kim SH: Female aging and superovulation induction for IVF. J Obstet Gynaecol 1995;21(1):75-82
5. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55(4):784-791
6. Cahill DJ, Prosser CJ, Wardle PG, Ford WC, Hull MG: Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994;101(11):999-1002
7. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA: Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;67(1):110-114
8. Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R, Winston RM: Follicular density in ovarian biopsy of infertile women: A novel method to assess ovarian reserve. Hum Reprod 1997;12(5):1028-1031
9. Lass A, Skull J, McVeigh E, Margara R, Winston RM: Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 1997;12(2):294-297
10. Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA: Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 1998;69(6):1010-1014
11. Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G, Winston R: Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod 2000;15(11):2297-2301
12. Frattarelli JL, Lauria-Costab DF, Miller BT, Bergh PA, Scott RT: Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 2000;74(3):512-517
13. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER: Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77(2):328-336
14. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K: Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53(2):295-301
15. Sharara FI, Scott RT, Jr, Seifer DB: The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998;179(3, Pt 1):804-812
16. Klein J, Sauer MV: Assessing fertility in women of advanced reproductive age. Am J Obstet Gynecol 2001;185(3):758-770
17. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B: Evaluating ovarian reserve: Follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 1996;11(3):486-489
18. Hull MG, Fleming CF, Hughes AO, McDermott A: The age-related decline in female fecundity: A quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril 1996;65(4):783-790
19. Hull MG, Armatage RJ, McDermott A: Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 1994;62(5):997-1003
20. Lashen H, Ledger W, Bernai AL, Barlow D: Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 1999;14(3):712-715
21. Karande V, Gleicher N: A rational approach to the management of low responders in in-vitro fertilization. Hum Reprod 1999;14(7):1744-1748
22. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM: Comparison of "poor" responders with "good" responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 1991;6(7):918-921
23. Keay SD, Lenton EA, Cooke ID, Hull MG, Jenkins JM: Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod 2001;16(9):1861-1865
24. Royston CG, Altman DG: Regression using fractional polynomials of continous covariates: Parsimonious parametric modelling. Appl Stat 1994;43:429-476
25. STATA: Reference Manual, Release 6. Texas, Stata Corp, 1999;2(202)
26. Kligman I, Rosenwaks Z: Differentiating clinical profiles: Predicting good responders, poor responders, and hyperresponders. Fertil Steril 2001;76(6):1185-1190
27. Faddy MJ, Gosden RG: A mathematical model of follicle dynamics in the human ovary. Hum Reprod 1995;10(4):770-775
28. Scott RT, Jr, Hofmann GE: Prognostic assessment of ovarian reserve. Fertil Steril 1995;63(1):1-11
29. Lenton EA, Sexton L, Lee S, Cooke ID: Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas 1988;10(1):35-43
30. Burger HG: Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition - An analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 1994;130(1):38-42
31. Nikolaou D, Lavery S, Turner C, Margara R, Trew G: Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002;17(4):1106-1111
32. Scott RT, Jr, Hofmann GE, Oehninger S, Muasher SJ: Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54(2):297-302
33. Balasch J, Creus M, Fabregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA: Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 1996;175(5):1226-1230
34. Creus M, Penarrubia J, Fabregues F, Vidai E, Carmona F, Casamitjana R, Vanrell JA, Balasch J: Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15(11):2341-2346
35. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT: Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76(4):666-669
36. Gurgan T, Urman B, Yarali H, Duran HE: Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol. Fertil Steril 1997;68(3):483-487
37. Roest J, van Heusden AM, Mous H, Zeilmaker GH, Verhoeff A: The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril 1996;66(6):969-973
38. Ranieri DM, Serhal P: Ovarian reserve: A simple mathematical problem? Hum Reprod 2000;15(6):1423-1424
39. Chappel SC: Heterogeneity of Follicle stimulating hormone: Control and physiological function. Hum Reprod Update 1995;1(5):479-487
40. Fauser BC, Van Heusden AM: Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 1997;18(1):71-106
41. Karande VC, Jones GS, Veeck LL, Muasher SJ: High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril 1990;53(3):486-489
42. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65(5):961-965
43. Khalaf Y, El-Toukhy T, Taylor A, Braude P: Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response. Eur J Obstet Gynecol Reprod Biol 2002;103(2):146-149
44. Lambalk CB, de Koning CH: Interpretation of elevated FSH in the regular menstrual cycle. Maturitas 1998;30(2):215-220